These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3469013)

  • 21. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition.
    Chow KC; Macdonald TL; Ross WE
    Mol Pharmacol; 1988 Oct; 34(4):467-73. PubMed ID: 2845248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podophyllotoxin derivatives VP-16 and VM-26.
    D'Incalci M; Garattini S
    Cancer Chemother Biol Response Modif; 1987; 9():67-70. PubMed ID: 3079416
    [No Abstract]   [Full Text] [Related]  

  • 24. Selection and characterization of L1210 sublines resistant to teniposide (VM-26).
    Lee T; Roberts D
    Cancer Res; 1984 Jul; 44(7):2981-5. PubMed ID: 6722821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells.
    Danks MK; Warmoth MR; Friche E; Granzen B; Bugg BY; Harker WG; Zwelling LA; Futscher BW; Suttle DP; Beck WT
    Cancer Res; 1993 Mar; 53(6):1373-9. PubMed ID: 8383009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities.
    Gupta RS; Singh B
    J Natl Cancer Inst; 1984 Jul; 73(1):241-8. PubMed ID: 6588229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Podophyllotoxin derivatives VP-16 and VM-26.
    D'Incalci M; Garattini S
    Cancer Chemother Biol Response Modif; 1988; 10():57-63. PubMed ID: 3079398
    [No Abstract]   [Full Text] [Related]  

  • 29. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE; Cadena RS; Raimondi SC; Beck WT
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA.
    Fernandes DJ; Danks MK; Beck WT
    Biochemistry; 1990 May; 29(17):4235-41. PubMed ID: 2163274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
    Vietti TJ; Valeriote FA; Kalish R; Coulter D
    Cancer Treat Rep; 1978 Sep; 62(9):1313-20. PubMed ID: 688275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.
    Roberts D; Lee T; Parganas E; Wiggins L; Yalowich J; Ashmun R
    Cancer Chemother Pharmacol; 1987; 19(2):123-30. PubMed ID: 3568269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies to glycoproteins of Vinca alkaloid-resistant human leukemic cells.
    Danks MK; Metzger DW; Ashmun RA; Beck WT
    Cancer Res; 1985 Jul; 45(7):3220-4. PubMed ID: 3891080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line.
    Feldhoff PW; Mirski SE; Cole SP; Sullivan DM
    Cancer Res; 1994 Feb; 54(3):756-62. PubMed ID: 8306338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts.
    Kalwinsky DK; Look AT; Ducore J; Fridland A
    Cancer Res; 1983 Apr; 43(4):1592-7. PubMed ID: 6572554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibitory effects of teniposide and homoharringtonine on the growth of pancreatic carcinoma cells in vitro.
    Fountzilas G; Lim LO; Yunis AA
    Anticancer Res; 1988; 8(3):343-6. PubMed ID: 3389738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
    Catchpoole DR; Stewart BW
    Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II.
    Campain JA; Padmanabhan R; Hwang J; Gottesman MM; Pastan I
    J Cell Physiol; 1993 May; 155(2):414-25. PubMed ID: 8097746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.